Post My Press Release

Free Press Release Distribution

Author: rohini (Page 1 of 179)

Physiotherapy Devices Market to Attain a Value of US$ 2,838.9 Mn by 2025

Global Physiotherapy Devices Market: Overview

The global physiotherapy devices market has been gaining a steady momentum in recent years due to a high incidence of injuries and ailments. Lifestyle changes, poor habits, and availability of physiotherapy services has boosted market growth in the past few years. On the other hand, the increasing participation in sporting activities has also had a positive impact in the overall market. According to the research report, the global physiotherapy devices market is likely to be worth US$2,838.9 mn by the end of 2025 from US$1,686.1 mn in 2016. During the forecast period of 2017 and 2025, the global market is expected to surge at a CAGR of 6.1%.

Based on product type, the global physiotherapy devices market is classified into equipment, kit and accessories. The equipment segment is estimated to claim the largest market share in 2016 followed by accessories and kit segments. On the other hand, the accessories segment is anticipated to witness higher growth compared to equipment and kit segments during the forecast period. The kit segment is minor contributor in this market. High price makes the equipment segment as the leading contributor in the global physiotherapy device market. Whereas rising awareness of the accessories among non-medical professionals is a potential reason for higher growth of the same segment in the forecast period.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=28517

Electrotherapy Emerges as Popular Equipment for Treating Ailments

The global physiotherapy devices market by equipment type has been segmented as hydrotherapy equipment, electrotherapy equipment, heat & cold therapy equipment and others. Among these four segments, electrotherapy segments holds the highest market share, significant market attractiveness, and exhibits highest growth rate in the forecast period. Easy availability, low price, and efficiency in pain reduction are the major factor for which electrotherapy equipment segment becomes a leading contributor in the market.

The application segment of the global physiotherapy devices market has been categorized as musculoskeletal, neurological, cardiovascular and others. The neurological segment claims the highest market share and noteworthy market attractiveness and exhibits highest growth rate in the forecast period followed by musculoskeletal, cardiovascular and others segments. The worldwide alarming rate of stroke and the rising prevalence of paralysis of the stroke patients are the key reasons for which neurological sector leads the total global market by application.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28517

By end user type, the global physiotherapy devices market is segmented into hospitals, physiotherapy clinics, rehabilitation centers, and others. Hospital and physiotherapy clinics segments claim the major share and show remarkable market attractiveness but the physiotherapy clinics segment represents higher growth rate (compared to hospital segment) in the forecast period. The availability of trained professionals, less-costly healthcare facilities, and effective results are the key drivers for the growth of the physiotherapy clinics segment.

North America to Lead Global Market due to Higher Awareness

Geographically, the global physiotherapy devices market is categorized into the North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The North America market holds the highest market share in 2016 and shows a potential market attractiveness but the Asia Pacific market represents a promising growth rate in the forecast period. The awareness of physiotherapy treatment, availability of trained professionals, and affordability of expensive devices are the key factors for making the North America region as the leading contributor in the market. On the other hand, the larger population pool and the growing awareness may be the prospective reasons for the Asia Pacific market for being a promising market in forecast period.

Prominent key players are DJO Global, EMS Physio Ltd., BTL, Patterson Medical Ltd., Enraf-Nonius, Dynatronics Corporation, Ossur, A. Alego Limited, HMS Medicals Systems. In 2015, DJO Global developed a complex wireless neuromuscular electronic stimulation product used for motor nerve and muscle fibers disorder. BTL launched BTL 6000 super inductive system elite based on high intensity electromagnetic field for fracture healing, and myorelaxation in 2016.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Flow Cytometry Market to Surge at a CAGR of 11.0% from 2017 to 2025

Global Flow Cytometry Market: Snapshot

The global market for flow cytometry is growing at a healthy pace and is likely to ensure high growth over the next few years. The increasing investments by the leading companies for the research and development activities is likely to accelerate the development of the overall market in the coming few years. In addition to this, the rise in the number of applications and the rising prevalence of diseases are projected to ensure the overall growth of the market in the coming years.

As per the market research study, in 2016, the global market for flow cytometry was worth US$3,072 mn and is projected to reach a value of US$8100 mn by the end of 2025. The market is further expected to register a promising 11.0% CAGR between 2017 and 2025.

Report Overview @ https://www.transparencymarketresearch.com/flow-cytometry-market.html

Increasing Stem Cell Research to Drive Flow Cytometry Market

A substantial rise in the adoption of flow cytometry techniques in the clinical trials and research activities is projected to encourage the growth of the global flow cytometry market in the next few years. The increasing prevalence of cancer and HIV/AIDS and the technological developments are anticipated to attract a large number of players, thus enhancing the market growth in the near future. In addition to this, the growing availability of novel application-specific flow cytometry products and the rising stem cell research are estimated to support the market growth in the near future.

On the contrary, the lack of skilled professionals and the lack of proper knowledge concerning the use of flow cytometry are predicted to restrict the market growth in the near future. Also, the high cost of flow cytometry products and the increasing complications concerning the reagent development are predicted to curb the development of market in the near future. Nonetheless, the rising focus of the players on the developing economies is anticipated to ensure the growth of the global flow cytometry market in the near future.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40472

North America Flow Cytometry to Witness High Growth in Near Future

The global market for flow cytometry has been categorized on the basis of geography into Latin America, North America, Asia Pacific, Europe, and the Middle East and Africa. In 2016, North America held a large share of the flow cytometry market and is predicted to continue with its position over the next few years. The rising prevalence of diseases and the rising contribution from the U.S. are some of the factors that are estimated to enhance the market growth in the coming few years. In addition, the rising number of cases of HIV and cancer and the rise in the use of flow cytometry for the drug discovery are projected to accelerate the growth of the overall market in the coming few years. Also, the rise in the development of new products is predicted to offer potential opportunities for the players in the coming few years.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40472

The global market for flow cytometry is considered as highly consolidated in nature, owing to the presence of a few players who are engaged in the market. These players are holding a huge share of the market and is likely to remain in a similar competitive environment in the next few years. The rising emphasis of the players on product development and the rise in the research and development activities are projected to encourage the growth of the flow cytometry market in the coming few years. Some of the key players engaged in the flow cytometry market across the globe are Bio-Rad Laboratories, Inc., Sysmex Partec GmbH, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., and Merck KGaA.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Fetal Bovine Serum Market to Attain a Value of US$ 1,396.1 Mn by 2025

Global Fetal Bovine Serum Market: Snapshot

The global market for fetal bovine serum is gaining momentum on the back of rising demand for fetal bovine serum for research studies. Fetal bovine serum is important for ground-breaking research in drug development and finds wide applications in cell-based pharmaceutical research. Fetal bovine serum is a key feedstock in pharmaceutical, diagnostics, biotechnology, diagnostic, and veterinary industries. Fetal bovine serum, a by-product of the beef industry is a crucial raw material for animal health, biotechnology, pharmaceutical research, and diagnostic as well as other research areas.

Report Overview @ https://www.transparencymarketresearch.com/fetal-bovine-serum-market.html

However, in the past few years, the fetal bovine serum industry is witnessing product shortage due to climatic uncertainties along with increased beef and dairy demand that has led to a drastic drop in cattle herd population lowest in 60 years.

As per projections of a market study by Transparency Market Research (TMR), the global fetal bovine serum market is anticipated to clock a healthy 8.0% CAGR for the forecast period between 2017 and 2025, for the market to be worth US$1,396.1 mn by the end of 2025 from its value of US$695.3 mn in 2016.

Cell Culture Media Application Segment to Continue to Remain in Lead

The report divides the global fetal bovine serum market based on a few parameters, viz. application, end-user, and region. Based on application type, the fetal bovine serum market is segmented into drug discovery, in vitro fertilization, cell culture media, diagnostics, human and animal vaccine production, and others. Vis-à-vis value and volume, the cell culture media segment led the market in 2016 and is anticipated to maintain its leading position over the forecast period owing to increasing cell culture applications of fetal bovine serum.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20606

Based on end-user type, the fetal serum bovine market is segregated into research and academic institutes and industry (pharma, biotech, etc.). The industry segment held the leading market share of the fetal bovine market in 2016 in terms of both value and volume. This is mainly because of increasing demand for fetal bovine serum from pharmaceutical and biotechnology industry.

Emergence of Contract Research Organizations to Make Asia Pacific Prominent Market

The global fetal bovine serum market has been segmented into five key regions, namely North America, Asia Pacific, Latin America, Europe, and the Middle East and Africa. Of them, in 2016, North America led the fetal bovine serum market vis-à-vis value due to the high consumption and high pricing of fetal bovine serum in the region. Europe is currently a significant market for fetal bovine serum; going forward, the region is anticipated to display declined growth because of religious sentiments and ethical issues pertaining to animal-derived products. Low pricing of fetal bovine serum also accounts for a low market share of Europe.

The Asia Pacific market for fetal serum bovine is anticipated to witness notable growth rate over the forecast period. The rapid emergence of contract research organizations in the region, especially in India and China is a key factor behind the growth of this regional market. Infrastructural development along with the presence of a large educated population pool are key factors behind the emergence of these countries as favored destinations for research pursuits. Large research organizations in the West are increasingly outsourcing research activities to these countries for relatively low cost without compromising on the quality of research.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20606

Prominent names in the fetal bovine serum market include Merck KGaA, Atlanta Biologicals Inc., Tissue Culture Biologicals, HiMedia Laboratories, Bovogen Biologicals Pty Ltd., TCS Biosciences Ltd., Rocky Mountain Biologicals , GE Healthcare, and PAN-Biotech.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Pediatric Radiology Market to Become Worth US$ 3.57 Bn by 2026

As imaging specialism continues to penetrate through the global healthcare landscape, the adoption of radiology in diagnosis and medical imaging operations continues to gain grounds, particularly in pediatric care. Protecting the new-born babies from suffering traumas during or post- birth has fuelled the demand for employing the subspecialty medical imaging science of radiology in pediatric diagnosis. In the future, hospitals and child specialty centers will actively install pediatric radiology devices to improve the diagnosis of young infants and children. However, growing speculations of parents with respect to radiation exposure continues to put pediatric radiology in a bad light. Moreover, education of pediatric radiology remains nascent and radiographers are facing challenges in being updated with the upgradations in pediatric imaging techniques.

Report Overview @ https://www.transparencymarketresearch.com/pediatric-radiology-market.html

Transparency Market Research’s latest forecast study observes that the global pediatric radiology market will expand vigorously in the near future. Despite the considerable restraints, the global adoption of pediatric radiology will reflect robust growth. During the forecast period, 2017-2026, the global pediatric radiology market will register a CAGR of 7.7%. The study further reveals that by the end of 2026, the global pediatric radiology market will touch a valuation of US$ 3.57 Bn. North America will represent the most lucrative marketplace for adoption of pediatric radiology devices. Robust healthcare infrastructure in the US, dense presence of medical device manufacturers and high spending of pediatric care will continue to drive the adoption of pediatric radiology in North America. By the end of 2026, North America’s pediatric radiology market will be worth one-third of global market value forecasted in the report.

Ultrasound Devices to Outsell X-ray Systems Towards the End of Forecast Period

Effectiveness of pediatric radiology devices in terms of producing quality images, integrating clinical information, and accurately assessing the conditions of the imaged body part continues to influence their sales. In 2017, around US$ 640 Mn worth of x-ray pediatric radiology devices were sold across the globe. The demand for x-ray systems will remain high in the first half of the forecast period, albeit, will dwindle towards the end of 2026. Adoption of ultrasound pediatric radiology devices is anticipated to gain traction. By 2026-end, over 40% of global pediatric radiology market value will be netted from sales of ultrasound systems and devices.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=39860

Hospitals to Represent Largest End-user; Standalone Modality to Remain Sought-After through 2026

Pediatric diagnosis is widely available across hospitals as parents are willing to spend on providing highest level of care for their babies. Reduced hospitalization time and immediate access to treatment options continue to drive hospitals in instating departments on pediatric radiology. By the end of 2026, pediatric radiology devices will be largely used in hospitals, bringing in nearly US$ 1.5 Bn in global revenues. Pediatric clinics, on the other hand, will register fastest end-use by reflecting a value CAGR of 10.9% during the forecast period. The report further reveals that standalone devices worth over US$ 1 Bn were sold in the global pediatric radiology market by 2017-end. In terms of modality, standalone devices will remain more convenient for diagnosis and high-tech imaging. The report also reveals that portable modality of pediatric radiology devices will register fastest uptake, reflecting a 9.5% CAGR over the forecast period.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39860

Global Pediatric Radiology Market: Key Stakeholders

Leading manufacturers of pediatric radiology devices have been profiled in the report. These include, Analogic Corporation, Esaote SpA, Fujifilm Corporation, General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Mindray Medical International Limited, Toshiba Corporation, Samsung Medison Co. Ltd., and Siemens AG. Majority of these companies are observed to invest in lowering the hazards of radiology techniques when used on infants and children. Several market players are also likely to introduce multipurpose pediatric radiology devices in the upcoming years.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Global Respiratory Monitoring Devices Market: Analyst’s Assessment

Respiration is an irreplaceable process of human lives, which starts at birth and continues uninterruptedly until death. A healthy human body is capable of respiration process for several decades but, owing to escalating levels of pollution in urban cities and lifestyles involving tobacco smoking, clogging of airways and other structures of the lung is turning into a common concern across the world. As a result of increasing prevalence of chronic respiratory diseases (CRDs), chronic obstructive pulmonary disease (COPD), and asthma, it has become imperative to frequently monitor respiration process. And the market for the devices that enable it, is flourishing. According to this business intelligence study, the demand in the global respiratory monitoring devices market will multiply at an impressive CAGR of 8.27% during the forecast period of 2017 to 2023. In terms of revenue, it has been estimated that the respiratory monitoring devices market, worldwide, will generate a demand worth of US$2,795.4 mn by the end of 2023, substantially more than the market’s evaluated worth of US$1,735.7 mn in 2017.

Report Overview @ https://www.transparencymarketresearch.com/respiratory-monitoring-devices.html

Apart from the growing prevalence of COPD, which the WHO has projected to be the third largest cause of deaths across the world by 2030, the demand in the global respiratory monitoring devices market is expected to gain traction from recent technological advancements and improving healthcare infrastructure in a number of emerging economies. On the other hand, high cost of devices and undefined reimbursement policies in rural parts of the world are a few restraints mitigating the prosperity of the respiratory monitoring devices market.

Pulse Oximeter & Spirometer In-demand Product Segments

On the basis of product, this report segments the respiratory monitoring devices market into capnographs, pulse oximeter, peak flow meter, and spirometer. Among these, as of 2017, the pulse oximeter and spirometer segments were in highest demand, respectively. A pulse oximeter measures the saturation of hemoglobin in arterial blood, i.e., the average amount of oxygen bound to each hemoglobin molecule. It is one the most commonly used monitoring modalities in a critical care setting and are very useful for patients suffering from respiratory or cardiac problems, especially COPD. Simplicity in usage and display of result within a short span of time are some of the other drivers of the growing demand for the segment of pulse oximeter. By the end of the forecast period of this report, 2023, the global pulse oximeter market is estimated to attain a valuation of US$937.8 mn.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1415

On the other hand, spirometer, which is a device used by physicians to measure and assess lung functions regarding respiratory problems such as bronchitis and asthma, is projected to produce a demand worth of US$855.4 mn by the end of 2023. Spirometers are mostly utilized in physician offices and clinical laboratories, as these provide more accurate and effective diagnostic results quicker than all commercially available lung function testing equipment.

Based on end users, the report bifurcates the respiratory monitoring devices market into laboratories, hospitals, and home use. The hospitals segment is expected to provide for the maximum chunk of demand until 2023, followed by laboratories.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1415

North America to Remain Most Profitable Region until 2023

Geographically, North America, Europe, and Asia Pacific have been identified as the three regions that will drive the demand in the respiratory monitoring devices market in the near future. In North America, the developed country of the U.S. is providing for the most prominent chunk of demand, which is a reflection of high awareness about spirometers and plethysmographs, and financial capability to purchase expensive machines. Moreover, prevalence of COPD, rising demand for technologically advanced and innovative products in hospitals, diagnostic laboratories, and outpatient ambulatory surgery centers would fuel market growth in the country. By the end of 2023, the North America respiratory monitoring devices market is estimated to be worth US$1,013.1 mn. While France, Germany, Spain, and the U.K. are the key countries in this market, vastly populated emerging economies of India and China are pushing the Asia Pacific respiratory monitoring devices market.

CareFusion Corporation, Smiths Medical, ResMed, Inc., Masimo Corporation, COSMED, GE Healthcare, MGC Diagnostic Corporation, and Medical Technologies, Inc. are some of the companies currently ahead of the curve in a largely fragmented competitive landscape of the global respiratory monitoring devices market.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Extracorporeal Membrane Oxygenation Machine Market is Expanding at a CAGR of 5.40% from 2017 to 2025

Global Extracorporeal Membrane Oxygenation Machine Market: Snapshot

The development of the healthcare facilities and the rising investment by the leading players have supported the growth of the global extracorporeal membrane oxygenation machine market in the last few years. The rising awareness among consumers and the willingness to spend a large amount on medical services are projected to enhance the growth of the market in the next few years.

According to the market research study published by Transparency Market Research, in 2016, the global market for extracorporeal membrane oxygenation machine was worth US$307.00 mn and is projected to reach a value of US$487.40 mn by the end of 2025. The market is likely to register a healthy 5.40% CAGR between 2017 and 2025.

Rise in Number of Extracorporeal Membrane Oxygenation Centers to Encourage Growth

The rising prevalence of respiratory and cardiovascular diseases and the rise in the number of ECMO centers are some of the major factors that are projected to encourage the growth of the global extracorporeal membrane oxygenation machine market in the next few years. The rise in the adoption of ECMO in lung transplantation procedures is another key factor that is likely to accelerate the growth of the market in the near future. In addition to this, the increasing research and development activities and technological advancements are projected to support the growth of the market and offer promising growth opportunities for the market players in the next few years.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=22187

On the flip side, the lack of skilled professionals and the high cost of extracorporeal membrane oxygenation procedures are considered as major challenges, which are expected to hamper the growth of the market in the near future. Moreover, the complications that are associated with these machines are estimated to restrict the market growth in the near future. Nonetheless, the rising survival rates with the use of extracorporeal membrane oxygenation machine is projected to accelerate the growth of the overall market in the next few years.

Rising Adoption of Advanced technology to Drive North America Market

The global market for extracorporeal membrane oxygenation machine has been classified on the basis of geography into Latin America, North America, the Middle East and Africa, Europe, and Asia Pacific. In 2016, North America led the global market and held a major share. This region is projected to continue with its dominance in the next few years, thanks to the availability of advanced healthcare infrastructure and the rising acceptance of technology. North America is projected to be followed by Europe, which is likely to maintain its second position in the next few years. The presence of several leading players and the high investments on research and development activities are projected to accelerate the growth of the market in the next few years. Furthermore, Asia Pacific is predicted to witness a high growth in the coming few years, owing to the rising prevalence of respiratory diseases, rising investments, and the development of the healthcare infrastructure.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=22187

The global market for extracorporeal membrane oxygenation machine is a highly competitive market with a huge number of players operating across the globe. The market is expected to witness an entry of new players in the next few years, thanks to which the level of competition is projected to increase significantly among the key players. The key players in the market are focusing on the innovative business strategies, which is projected to enhance the competitive environment of the market and support the key players for market penetration across the globe. In addition to this, the development of new products and the increasing research and development activities are estimated to accelerate the growth of the overall market in the coming few years. Furthermore, the rising mergers and acquisitions and collaborations are predicted to offer promising growth opportunities for the market players in the next few years. Some of the key players operating in the extracorporeal membrane oxygenation machine market across the globe are Getinge AB, EUROSETS, LivaNova PLC., Terumo Corporation, Medtronic plc., Hemovent GmbH, XENIOS AG, and Nipro Corporation.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Lipid Disorder Treatment Market will Register a CAGR of 7.4% from 2017 to 2026

Emergence of various lifestyle diseases has been witnessed worldwide, especially among teens and people lying in the 50-60 years age group. Lipid disorders are largely caused due to high cholesterol and triglycerides, which ultimately can result in increased chances of heart diseases, which has prompted the development of safe and efficient treatments for lipid disorders. Moreover, smoking and drinking have largely contributed to the rising prevalence of lipid disorders and other cardiovascular diseases among men and women. This has fuelled demand for advanced treatments such as introduction of modern lipid lowering drugs. The demand for lipid disorder treatments has risen owing to occupational diseases caused by higher consumption of alcohol results in rising amount of bad cholesterol or LDL, irregular eating habits, lack of body exercises and improper medication.

Report Overview @ https://www.transparencymarketresearch.com/lipid-disorder-treatment-market.html Analysis of Transparency Market Research shows that the global market for lipid disorder treatment is expected to grow at an exceptional pace during the period of assessment. This growth is fuelled by rising demand for modern lipid metabolism disorder treatments coupled with increased chances of cardiovascular diseases across the globe. The global market for lipid disorder treatment is poised to register a value CAGR of 7.4% during the period of assessment, 2017-2026.

Several biopharma companies are focusing on developing effective solutions for treating lipid disorders. Companies involved in lipid disorder treatment market include Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd., and Wockhardt Limited.

Request A Sample Copy @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40640

Sales of Drugs to Treat Lipid Disorders to Remain High in North America

United States has registered a higher number of people acquiring lipid disorders, especially among adults. Growing consumption of drugs such as atorvastatin and fluvastatin to treat hypercholesterolemia and other associated lipid disorders has been witnessed in the country. Several tests have been performed to identify patients who have a high risk of developing lipid disorders owing to family history or genetic disorders. According to American Academy of Pediatrics and National Heart, Lung and Blood Institute, atherosclerotic cardiovascular disease is a leading cause of death in the region.

This has pushed the use of prescription drugs in the region, making it imperative for pharma companies to increase their production rate and revise their production cycles. In addition, screening for lipid disorders in childhood has been initiated in the region, and as per study, a moderate percentage of children population in the United States is being affected by lipid disorders, that typically surface as the child reaches its teenage. This has presented potential opportunities for sale of drugs for the treatment of lipid disorders in North America, making it an attractive region from a business point of view.

Request Brochure @  https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=40640

Atorvastatin to Witness Increased Demand for Lipid Disorder Treatment

As the risk of developing lipid disorders increases, pharmaceutical companies have initiated drug enhancement, introduction of new drugs and conducting phase trials of these drugs on a large scale. Statins are considered to be highly effective in lowering the rate cardiovascular events. Most companies are focusing on mass production of atorvastatin as they are a highly effective low density lipoprotein lowering agents, LDL being the main cause of lipid disorders and associated heart diseases. The consumption of atorvastatin is expected to grow at a higher rate. Market for atorvastatin is poised to reach a value of over US$ 16 Bn by the end of the assessment period.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us

Transparency Market Research

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com

Stromal Vascular Fraction Market Competitive Analysis 2018 to 2026

Global Stromal Vascular Fraction Market: Snapshot

Stromal vascular fraction is kind of a skin treatment method, which is based on of stem cell therapy. It is performed by utilizing isolation of adipose tissue at the time of lipo-aspiration or liposuction or process in the patients. The isolation process in the stromal vascular fraction treatment, the blood cells, tissue containing fat cells, a large amount of adipose-derived mesenchymal stem cells, and endothelial cells are used.  This method hold various helpful anti-ageing and regenerative properties. The stromal vascular fraction method is foreseen to be a customized stem cell therapy and helpful injectable and tropical treatment.

Report Overview @ https://www.transparencymarketresearch.com/stromal-vascular-fraction-market.html

The global stromal vascular fraction market is prognosticated to expand at a decent CAGR within the forecast period from 2017 to 2025. The stromal vascular fraction market is likely to witness a moderate growth in coming years. The stromal vascular fraction market is presently in its initial stage and hence holds a huge scope of exploration and growth, along with the growth in efficiency, precision, and safety of SVF devices. The stromal vascular fraction market is prognosticate to be led by segment of soft tissue, as it has various applications such as cosmetic breast augmentation, post-mastectomy breast reconstruction, sports injuries, scleroderma, burn and trauma injuries, and DFU (diabetic foot ulcer). Moreover, even the segment of cosmetic applications is foreseen to pick up a rapid pace in coming years due to rise in people being more conscious about their personality and beauty.

Request Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=49587

Global Stromal Vascular Fraction Market: Trends and Opportunities

Since the regenerative medicine segment is still a controversial one, global stromal vascular fraction market is likely to face tough debates between regulators, lawmakers, and medical practitioners. This turned out as a significant factor related to uncertainty in quality, safety, and efficiency of the information that in the end obstructs the rate of adoption of SVF treatments and gadgets utilized amid the procedure of stromal vascular fraction treatment. The stromal vascular fraction market is at present is witnessing the increased adoption of the PoC (point of-care) gadgets, credited to a comparatively higher comfort level related with their utilization.

A rising inclination in the direction of value based model of medical delivery and extensively growing expenditure on healthcare worldwide is likely to sustain as the noteworthy driving factors to stromal vascular fraction market development. A couple of recent patterns have been seen to boost stromal vascular fraction market development, including shift towards higher comfort, effective improvement of PoC gadgets, and cost-effectiveness over customary fat-grafting treatments such as liposuction, clinical accomplishment of advanced fat – inferred SVF treatments, and a general medical results. In addition, the stromal vascular fraction market is foreseen to profit by a huge pipeline of an extensive variety of SVF-determined cell treatments.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=49587

Global Stromal Vascular Fraction Market: Regional Analysis

On the basis of region, the North America is seen to continue to account for the highest share as far as value in concerned. Nevertheless, Europe and Asia Pacific are also foreseen to emerge as major markets in the upcoming years. As per the report, Asia Pacific is expected to experience a higher CAGR value as compared to Europe and North America, whereas the market of South Korea for SVF treatment is anticipated to witness the most rapid growth within the forecast period, which is likely to turn out into highest CAGR in the stromal vascular fraction market.

Global Stromal Vascular Fraction Market: Competitive Landscape

The major players which are operating in the global stromal vascular fraction market, along with being financially active in terms of competitive scenario are IntelliCell BioSciences Inc., Cytori Therapeutics Inc., Cellular Biomedicine Group, Inc., InGeneron, Inc., Lifecell Corporation (Allergen PLC), GE Healthcare (Biosafe Group SA), and Tissue Genesis Inc.

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

Page 1 of 179

Powered by WordPress & Theme by Anders Norén